Showing 386 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP science

Older age and baseline kidney function are the key risk factors for renal dysfunction while taking HIV PrEP

News
23 March 2020
PrEP science

F/TAF and F/TDF Efficacy and Safety as PrEP for 96 Weeks

Editor's pick
NATAP
20 March 2020
PrEP science

Diagnostic challenges with PrEP use during early HIV infection

News
18 March 2020
PrEP science

Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds

News
13 March 2020
PEP

New PEP studies revive interest in post-exposure prevention

News
11 March 2020
PrEP science

NIH study finds lower concentration of PrEP drug in pregnant teens & young women

Editor's pick
National Institutes of Health
10 March 2020
Undetectable viral load & treatment as prevention

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention

News
10 March 2020
PrEP science

Uptick in Statin Use After Descovy in HIV PrEP

Editor's pick
Medscape (requires free registration)
9 March 2020
Transgender people

HIV drugs reduce feminising hormone levels by 36% in HIV-positive trans women, Thai study finds

News
14 February 2020
PrEP science

Does PrEP cause more HIV drug resistance? Yes, some

News
12 February 2020
PrEP science

Researchers launch study to assess safety of PrEP and dapivirine ring in pregnant women

Editor's pick
EurekAlert
11 February 2020
Side effects

PrEP in pregnancy: safe, but many unanswered questions

News
7 February 2020
PrEP science

HIV PrEP could also lead to big reductions in gonorrhoea, Dutch study finds

News
23 January 2020
PrEP policies & guidelines

Truvada, not Descovy, should be the first choice for PrEP, US experts say

News
14 January 2020
Bad science & bogus treatments

Facebook disables some misleading ads on HIV prevention drugs, responding to growing outcry

Editor's pick
Washington Post
2 January 2020
PrEP science

Facebook ads push misinformation about HIV prevention drugs, LGBT activists say, ‘harming public health’

Editor's pick
Washington Post
10 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
PrEP science

Serosorting between gay men may be in decline as ‘PrEP sorting’ rises, Canadian study finds

News
20 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
PrEP programmes & uptake

French study finds one in six stops PrEP within 12 months, one in three after 30 months

News
11 November 2019
PrEP science

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Editor's pick
Monthly Prescribing Reference
8 November 2019